PLCD1 and malignant colon neoplasm: In colon cancer, the downregulation of PLCδ1 leads to a reduction in cellular apoptosis and an increase in cellular proliferation, invasion, and migration; therefore, PLCδ1 is described as a potential biomarker of colon cancer [59].